Trial Profile
Phase 2a study of CIRARA in patients with Subarachnoid Hemorrhage (SAH)
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Jun 2016
Price :
$35
*
At a glance
- Drugs Glibenclamide (Primary)
- Indications Subarachnoid haemorrhage
- Focus Therapeutic Use
- 10 Jun 2016 New trial record